| Wilson Tong, MD | |
|
4721 Dallas Ranch Rd, Antioch, CA 94531-8811 | |
| (925) 778-0679 | |
| (925) 778-3567 |
| Full Name | Wilson Tong |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 17 Years |
| Location | 4721 Dallas Ranch Rd, Antioch, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427261437 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | A116219 (California) | Primary |
| 207R00000X | Internal Medicine | 40846 (Arizona) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sutter Delta Medical Center | Antioch, CA | Hospital |
| John Muir Medical Center - Concord Campus | Concord, CA | Hospital |
| John Muir Medical Center - Walnut Creek Campus | Walnut creek, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Epic Care | 5890053094 | 45 |
News Archive
VIDA Diagnostics, a leading developer of quantitative imaging software for the advanced analysis of pulmonary diseases, and Veran Medical Technologies, a leader in minimally invasive delivery of interventional oncology therapies, announced the companies have signed a definitive agreement covering joint development and distribution of an endobronchial lung navigation and biopsy system.
Emory University Rollins School of Public Health researchers will present Nov. 11 on a range of topics at the American Public Health Association's annual meeting in Philadelphia, including a study that found reduced absenteeism among employees participating in a large-scale worksite wellness program.
In just over a month following the FDA's October 2010 approval of Roche's Herceptin for HER2-positive metastatic gastric cancer, more than 80 percent of U.S. physicians report using the drug, according to new research by GfK HealthCare.
Some 20 percent of breast cancer survivors will suffer from lymphedema, a potentially severe side effect of treatment that makes arms swell with lymph. The disease is often overlooked, but commercially available app-based technology now makes early detection easier, allowing for proactive treatment.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
› Verified 2 days ago
| Entity Name | John Muir Trauma Physicians Billing Service |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093864837 PECOS PAC ID: 3476542515 Enrollment ID: O20050420001452 |
News Archive
VIDA Diagnostics, a leading developer of quantitative imaging software for the advanced analysis of pulmonary diseases, and Veran Medical Technologies, a leader in minimally invasive delivery of interventional oncology therapies, announced the companies have signed a definitive agreement covering joint development and distribution of an endobronchial lung navigation and biopsy system.
Emory University Rollins School of Public Health researchers will present Nov. 11 on a range of topics at the American Public Health Association's annual meeting in Philadelphia, including a study that found reduced absenteeism among employees participating in a large-scale worksite wellness program.
In just over a month following the FDA's October 2010 approval of Roche's Herceptin for HER2-positive metastatic gastric cancer, more than 80 percent of U.S. physicians report using the drug, according to new research by GfK HealthCare.
Some 20 percent of breast cancer survivors will suffer from lymphedema, a potentially severe side effect of treatment that makes arms swell with lymph. The disease is often overlooked, but commercially available app-based technology now makes early detection easier, allowing for proactive treatment.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
› Verified 2 days ago
| Entity Name | Epic Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780107797 PECOS PAC ID: 5890053094 Enrollment ID: O20171215002809 |
News Archive
VIDA Diagnostics, a leading developer of quantitative imaging software for the advanced analysis of pulmonary diseases, and Veran Medical Technologies, a leader in minimally invasive delivery of interventional oncology therapies, announced the companies have signed a definitive agreement covering joint development and distribution of an endobronchial lung navigation and biopsy system.
Emory University Rollins School of Public Health researchers will present Nov. 11 on a range of topics at the American Public Health Association's annual meeting in Philadelphia, including a study that found reduced absenteeism among employees participating in a large-scale worksite wellness program.
In just over a month following the FDA's October 2010 approval of Roche's Herceptin for HER2-positive metastatic gastric cancer, more than 80 percent of U.S. physicians report using the drug, according to new research by GfK HealthCare.
Some 20 percent of breast cancer survivors will suffer from lymphedema, a potentially severe side effect of treatment that makes arms swell with lymph. The disease is often overlooked, but commercially available app-based technology now makes early detection easier, allowing for proactive treatment.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wilson Tong, MD 4721 Dallas Ranch Rd, Antioch, CA 94531-8811 Ph: (925) 778-0679 | Wilson Tong, MD 4721 Dallas Ranch Rd, Antioch, CA 94531-8811 Ph: (925) 778-0679 |
News Archive
VIDA Diagnostics, a leading developer of quantitative imaging software for the advanced analysis of pulmonary diseases, and Veran Medical Technologies, a leader in minimally invasive delivery of interventional oncology therapies, announced the companies have signed a definitive agreement covering joint development and distribution of an endobronchial lung navigation and biopsy system.
Emory University Rollins School of Public Health researchers will present Nov. 11 on a range of topics at the American Public Health Association's annual meeting in Philadelphia, including a study that found reduced absenteeism among employees participating in a large-scale worksite wellness program.
In just over a month following the FDA's October 2010 approval of Roche's Herceptin for HER2-positive metastatic gastric cancer, more than 80 percent of U.S. physicians report using the drug, according to new research by GfK HealthCare.
Some 20 percent of breast cancer survivors will suffer from lymphedema, a potentially severe side effect of treatment that makes arms swell with lymph. The disease is often overlooked, but commercially available app-based technology now makes early detection easier, allowing for proactive treatment.
Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife's research project for optimized culture media to enable the clinical use of stem cells. "It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future", says Magnus Nilsson, Vitrolife's CEO.
› Verified 2 days ago
Chung M. Kung, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 5601 Deer Valley Rd, Antioch, CA 94531 Phone: 925-813-6500 | |
Prasad Pillai, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4721 Dallas Ranch Rd, Antioch, CA 94531 Phone: 925-778-0679 Fax: 925-778-3567 | |
Dr. Doris Sofia Galina-da Silva, DORIS GALINADA SILVA Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2370 Country Hills Dr Ste 101, Antioch, CA 94509 Phone: 925-779-9635 Fax: 925-779-9672 | |
Dr. Patricia Anne Yabut Haro, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3901 Lone Tree Way, Antioch, CA 94509 Phone: 916-854-6975 Fax: 916-854-6844 | |
Dr. Kalyani Maganti, M.D. Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 3903 Lone Tree Way, Suite 205, Antioch, CA 94509 Phone: 925-754-8710 Fax: 925-754-0765 | |
Al G. Sumaquial, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3400 Delta Fair Blvd, Antioch, CA 94509 Phone: 925-779-5000 | |
Veenu Goel Gupta, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3901 Lone Tree Way, Antioch, CA 94509 Phone: 925-756-1192 |